Lumryz is an extended-release formulation of sodium oxybate, a central nervous system (CNS) depressant. Its therapeutic effects are believed to be mediated through GABA B actions at noradrenergic and ...
DUBLIN - Avadel Pharmaceuticals plc (NASDAQ:AVDL) announced that the U.S. Food and Drug Administration (FDA) has approved its once-at-bedtime narcolepsy medication, LUMRYZ, for pediatric patients ...
Some results have been hidden because they may be inaccessible to you